Company profile: Applied Proteomics
1.1 - Company Overview
Company description
- Provider of protein biomarker discovery solutions, including SimpliPro Colon Testβa blood test for healthcare providers to aid colorectal health assessment by measuring 11 protein markers associated with colorectal cancer and advanced adenomaβplus a mass-spectrometry (tandem LCMS) proteomics platform, proprietary workflow management system, and advanced visualization tools.
Products and services
- Proteomics Platform: A tandem LCMS-based, mass-spectrometry approach that studies many proteins at once in biological systems for biomarker discovery
- SimpliPro Colon Test: A blood-based test available only to healthcare providers, aiding colorectal health assessment by measuring 11 protein markers associated with colorectal cancer and advanced adenoma risk
- Workflow Management System (WMS): A proprietary command-and-control toolset that records experimental details and enables real-time feedback and process modification to minimize noise in proteomics experiments
Key contacts
π
π
Financial details
π
1.2 - Competitors and similar companies to Applied Proteomics
Fate Therapeutics
HQ: United States
Website
- Description: Provider of iPSC-derived cellular therapeutics and platform technologies, offering a proprietary clonal master iPSC platform for off-the-shelf therapies; CAR T and CAR NK candidates including FT819 (CD19 for systemic lupus erythematosus and other autoimmune diseases), FT522 (CAR NK with alloimmune defense receptor for B-cell lymphoma and autoimmune diseases), FT825 (HER2 solid tumors), plus NK and T-cell programs for cancer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Fate Therapeutics company profile β
Broncus Medical
HQ: United States
Website
- Description: Provider of minimally invasive medical devices for emphysema and other lung diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Broncus Medical company profile β
IsoRay
HQ: United States
Website
- Description: Provider of state-of-the-art, personalized brachytherapy products that offer more cost-effective cancer treatment, utilizing a unique isotope for the treatment of both common and difficult-to-treat cancers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full IsoRay company profile β
Cartesian Therapeutics
HQ: United States
Website
- Description: Provider of potent, safer cell therapy in and beyond oncology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Cartesian Therapeutics company profile β
Origo Biopharma
HQ: Spain
Website
- Description: Provider of research and development of immunotherapeutic products targeting health disorders related to TGF-beta signaling dysfunction, including cancer and fibrosis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Origo Biopharma company profile β
π
2.M&A buyers
2.1 Potential strategic acquirers in the sector
π
π
π
π
View all strategic buyers with complete profiles
Start Free Trial β
2.2 - Strategic buyer groups for Applied Proteomics
π
Buyer group 1: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 2: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 3: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial β
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Applied Proteomics
2.2 - Growth funds investing in similar companies to Applied Proteomics
π
View all growth equity funds with complete profiles
Start Free Trial β
4 - Top valuation comps for Applied Proteomics
4.2 - Public trading comparable groups for Applied Proteomics
π Unlock all public trading comparable groups with complete valuation data
Start Free Trial β